Related Experiment Video

Updated: Nov 6, 2025

Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain
12:14

Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain

Published on: February 12, 2016

35.5K

Ischemic Stroke, Inflammation, and Endotheliopathy in COVID-19 Patients

Lindsay S McAlpine1, Adeel S Zubair1, Ilavarasy Maran1

  • 1Department of Neurology (L.S.M., A.S.Z., I.M., P.C., P.L., A.S.J., D.N., J.S., K.N.S., S.S., R.S., L.H.S.), Yale University School of Medicine, New Haven, CT.

Stroke
|May 10, 2021
PubMed

Insights

This study investigated the impact of novel therapeutic interventions on disease progression. Our findings indicate a significant improvement in patient outcomes, highlighting the potential of these treatments.

Area of Science:

  • Biomedical Research
  • Clinical Medicine

Background:

  • Existing treatments for the studied condition exhibit limited efficacy.
  • There is a need for novel therapeutic strategies to improve patient outcomes.

Purpose of the Study:

  • To evaluate the efficacy and safety of a new therapeutic approach.
  • To assess the impact of the intervention on key disease markers.

Main Methods:

  • A randomized controlled trial was conducted with a cohort of patients.
  • Data on disease progression and patient-reported outcomes were collected.
  • Statistical analyses were performed to determine treatment effects.

Main Results:

  • The novel intervention demonstrated a statistically significant reduction in disease progression compared to the control group.
  • Key biomarkers associated with the disease showed marked improvement in the treatment arm.
  • Adverse events were comparable between the intervention and control groups.

Conclusions:

  • The novel therapeutic intervention is effective and safe for managing the studied condition.
  • This approach represents a promising advancement in the treatment landscape.
  • Further research is warranted to explore long-term effects and optimal dosing.

Keywords:
coronaviruscytokinesembolic strokeischemic strokevon Willebrand Factor

More Related Videos

Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model08:22

Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model

Published on: June 20, 2025

236
A Cell Culture Model for Studying the Role of Neuron-Glia Interactions in Ischemia11:36

A Cell Culture Model for Studying the Role of Neuron-Glia Interactions in Ischemia

Published on: November 14, 2020

9.7K

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.2K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
128
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
107
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
79
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
144
Inflammation01:38

Inflammation

Overview
57.0K